SPRYD7 was described in a multi-dimensional proteomics analysis of CRC metastasis as significantly upregulated in the membrane compartment of KM12SM liver-metastatic CRC cells in comparison to isogenic poorly metastatic KM12C cells (Figure 1A) [15]. The gene discussed is SPRYD7; the disease is colorectal carcinoma.